L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents

Place in the ATC classification

1. L Antineoplastic and immunomodulating agents 1,791 medicines
   1. L01 Antineoplastic agents 1,025 medicines
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
         1. L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
         2. L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
         3. L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 6 medicines
         4. L01ED Anaplastic lymphoma kinase (ALK) inhibitors 14 medicines
         5. L01EE Mitogen-activated protein kinase (MEK) inhibitors 10 medicines
         6. L01EF Cyclin-dependent kinase (CDK) inhibitors 13 medicines
         7. L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 27 medicines
         8. L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 4 medicines
         9. L01EJ Janus-associated kinase (JAK) inhibitors 18 medicines
         10. L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 12 medicines
         11. L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
         12. L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
         13. L01EX Other protein kinase inhibitors 94 medicines

Medicines in the group and its subgroups